<DOC>
	<DOC>NCT01490268</DOC>
	<brief_summary>The purpose of this study is to determine generation of a target controlled infusion model for the patient controlled analgesia with the strong analgesic, hydromorphone, after planned open heart surgery, during which the strong analgesic, sufentanil, was used.</brief_summary>
	<brief_title>Pain Therapy After Elective Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Written informed consent, Ability to understand the nature of patientcontrolled analgesia and other studyspecific procedures, Elective cardiac surgery with thoracotomy and subsequent stay in the intensive care unit Use of MAO inhibitors in the last 14 days, Chronic alcoholism or drug addiction in medical history, Severe obstructive or restrictive pulmonal disorders in medical history, Severe hepatic and renal disorders in medical history, Hypothyroidism, pancreatitis in medical history, ASA IV, Pregnant or nursing females</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Pharmacokinetic-pharmacodynamic modeling</keyword>
	<keyword>Patient-controlled analgesia</keyword>
	<keyword>Target-controlled infusion</keyword>
	<keyword>Hydromorphone</keyword>
	<keyword>Sufentanil</keyword>
	<keyword>after thoracotomy</keyword>
	<keyword>cardiac surgery</keyword>
</DOC>